QuickView for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=F814328285108F7A4EA0DA28CFE696D7;jsessionid=502E776C630F24248151AAEED05D5B46;jsessionid=FE390919606FA9CDF00B0C61A4202833;jsessionid=12E26BE49F608DA880933580566077C6;jsessionid=2333D5F98CAB448A7222F81C5FB26A40;jsessionid=D35B492B29ECB8B95786F93BA851481D;jsessionid=34E7645A4F01323AA5D944EE56C3BC54;jsessionid=133C5263DD26522F046DC5D2010DFC6B (gene)

1. Ataxin-2 sequesters Raptor into aggregates and impairs cellular mTORC1 signaling.
2. The polyglutamine protein ATXN2: from its molecular functions to its involvement in disease.
3. Clinical features, disease progression, and nuclear imaging in ATXN2-related parkinsonism in a longi…
4. ATXN2 is a target of N-terminal proteolysis.
5. A Case of Coexistent Spinocerebellar Ataxia Type 2 and Primary Progressive Multiple Sclerosis-Coinci…

There were no clinical trials for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=F814328285108F7A4EA0DA28CFE696D7;jsessionid=502E776C630F24248151AAEED05D5B46;jsessionid=FE390919606FA9CDF00B0C61A4202833;jsessionid=12E26BE49F608DA880933580566077C6;jsessionid=2333D5F98CAB448A7222F81C5FB26A40;jsessionid=D35B492B29ECB8B95786F93BA851481D;jsessionid=34E7645A4F01323AA5D944EE56C3BC54;jsessionid=133C5263DD26522F046DC5D2010DFC6B